Cohort study demonstrates enhanced bronchopulmonary dysplasia-free survival in extremely preterm infants with hydrocortisone treatment, suggesting potential benefits.
In this cohort study of extremely preterm infants, the introduction of prophylactic hydrocortisone was associated with increased survival without BPD, after adjusting for covariates. There was no significant increase in severe neonatal morbidities, except that late-onset bacterial infection was more common in the exposed group before adjustments.
No takes yet. Share an insight, caveat, or question.
Smedbäck et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: